The spironolactone renaissance

@article{Doggrell2001TheSR,
  title={The spironolactone renaissance},
  author={S. Doggrell and Lindsay Brown},
  journal={Expert Opinion on Investigational Drugs},
  year={2001},
  volume={10},
  pages={943 - 954}
}
Until recently, spironolactone was considered only as an antagonist at the aldosterone receptors of the epithelial cells of the kidney and was used clinically in the treatment of hyperaldosteronism and, occasionally, as a K+-sparing diuretic. The spironolactone renaissance started with the experimental finding that spironolactone reversed aldosterone-induced cardiac fibrosis by a cardiac action. Experimentally, spironolactone also has direct effects on blood vessels. Spironolactone reduces… Expand
Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs
Aldosterone, mineralocorticoid receptor, and heart failure
Central mineralocorticoid receptor blockade decreases plasma TNF-alpha after coronary artery ligation in rats.
Determinants of spironolactone binding specificity in the mineralocorticoid receptor.
Present and future pharmacotherapy for heart failure
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 70 REFERENCES
Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension.
Effect of spironolactone and its metabolites on contractile property of isolated rat aorta rings.
...
1
2
3
4
5
...